Bio-techne Corp. Stock Performance
as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
$56.53$58.04
1.52%
Downside
1.11%
Upside
52 Week's Low
52 Week's High
$46.01$79.2819.84%
Downside
38.12%
Upside
Bio-techne Corp. share price movements today
- Previous Close
- $58.18
- Open
- $57.76
- Volume
- 1.1M
- Day's Low - High
- $56.53 - $58.04
- 52 Week Low - High
- $46.01 - $79.28
Bio-techne Corp. Historical Returns
- 1 Month Return
- -5.2 %
- 3 Month Return
- + 13.86 %
- 1 Year Return
- -24.42 %
- 3 Year Return
- -26.02 %
- 5 Year Return
- -24.08 %
Bio-techne Corp. Stock Fundamentals & Key Indicators
Check Bio-techne Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.1B
EPS (TTM)
1.9075
Dividend Yield
0.43%
Quarterly Earnings Growth YOY
0.14%
PE Ratio (TTM)
118.73
Industry PE ratio
19.200384615384614
PEG Ratio
0.8316
EBITDA
334.8M
Revenue (TTM)
1.2B
Profit Margin
6.41%
Return On Equity TTM
3.80%
Bio-techne Corp. Stock Valuation
Track how Bio-techne Corp. P/E has moved over time to understand its valuation trends.
Bio-techne Corp. in the last 5 years
Lowest (26.04x)
June 30, 2025
Industry (19.20x)
November 8, 2025
Today (118.73x)
November 8, 2025
Highest (67.99x)
September 30, 2021
Today’s Price to Earnings Ratio: 118.73x
Bio-techne Corp. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bio-techne Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $9.1B | -24.08% | 118.73 | 6.41% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
Stock Returns calculator for Bio-techne Corp. Stock including INR - Dollar returns
The Bio-techne Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bio-techne Corp. investment value today
Current value as on today
₹80,673
Returns
Returns from Bio-techne Corp. Stock
Dollar Returns*
₹5,107 (+5.11%)
Analyst Recommendation on Bio-techne Corp. Stock
Based on 19 analysts
84.21%
Buy
15.79%
Hold
0.00%
Sell
Based on 19 analysts, 84.21% of analysts recommend a 'BUY' rating for Bio-techne Corp.. Average target price of $67.83
Bio-techne Corp. Share Price Target
Get share price movements and forecasts by analysts on Bio-techne Corp..
What analysts predicted
15.38%UPSIDE
Target Price
$67.83
Current Price
$57.4
Analyzed by
19 Analysts
Target
$67.83
Bio-techne Corp. target price $67.83, a slight upside of 15.38% compared to current price of $57.4. According to 19 analysts rating.
Bio-techne Corp. Stock’s Investor Sentiment and Interest
Search interest for Bio-techne Corp. Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
Bio-techne Corp. Quarterly Profit & Loss
All numbers in Millions USD
Bio-techne Corp. Annual Profit & Loss
All numbers in Millions USD
Bio-techne Corp. Quarterly Cash Flow
All numbers in Millions USD
Bio-techne Corp. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Bio-techne Corp. Stock
Check out the Mutual Funds with significant holdings in Bio-techne Corp..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.01678% | 1237 |
Global Institutional Holdings in Bio-techne Corp.
Bio-techne Corp. News & Key Events
Today's Timeline - 05 November
Wed, 06:18 PM
-Bio-Techne faces stock volatility due to slight revenue decline, despite improved operating margins and growth in certain segments.
Wed, 09:15 PM
-William Blair maintains Buy rating on Bio-Techne, citing strong profitability despite revenue challenges.
Wed, 09:22 PM
-Bio-Techne reported Q1 fiscal 2026 adjusted EPS of 42 cents, matching estimates, but revenue missed expectations.
Today's Timeline - 05 November
Wed, 11:28 PM
-Bio-Techne's stock fell 2.7% after missing revenue expectations for Q1 fiscal 2026, reporting $286.6 million.
Insights on Bio-techne Corp.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -17.67M → 38.18M (in $), with an average increase of 146.3% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 922.2%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 175.9%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 316.96M → 286.55M (in $), with an average decrease of 9.6% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, TECH stock has moved down by -7.0%
About Bio-techne Corp.
| Organisation | Bio-techne Corp. |
| Headquarters | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 |
| Industry | Health Technology |
| CEO | Mr. Kim Kelderman |
| E-voting on shares | Click here to vote |
Key Management of Bio-techne Corp.
Name | Title |
|---|---|
Ms. Cheryl Bethune | Senior VP & Chief Human Resources Officer |
Mr. Kim Kelderman | CEO, President & Director |
Mr. James T. Hippel CPA | Executive VP of Finance & CFO |
Mr. William A. Geist | President of Protein Sciences Segment |
Dr. Matthew F. McManus M.D., MBA, Ph.D. | President of Diagnostics & Spatial Biology |
Mr. Gerry Andros | Vice President of Sales and Marketing |
Mr. Martin Wirtz | Senior Vice President of Strategy & Corporate Development |
Mr. Shane Bohnen | Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer |
Dr. Gary J. Latham Ph.D. | VP & CTO |
Mr. David Clair C.F.A. | VP of Investor Relations & Corporate Development |
FAQs
What is Bio-techne Corp. share price today?
Bio-techne Corp. share price today is $57.4 as on at the close of the market. Bio-techne Corp. share today touched a day high of $58.04 and a low of $56.53.
What is the 52 week high and 52 week low for Bio-techne Corp. share?
Bio-techne Corp. share touched a 52 week high of $79.28 on and a 52 week low of $46.01 on . Bio-techne Corp. stock price today i.e. is closed at $57.4,which is 27.60% down from its 52 week high and 24.76% up from its 52 week low.
What is Bio-techne Corp.'s market capitalisation today?
Bio-techne Corp. market capitalisation is $0.01T as on .
How to invest in Bio-techne Corp. Stock (TECH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bio-techne Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bio-techne Corp. Shares that will get you 0.0261 shares as per Bio-techne Corp. share price of $57.4 per share as on November 8, 2025 at 2:29 am IST.
What is the minimum amount required to buy Bio-techne Corp. Stock (TECH) from India?
Indian investors can start investing in Bio-techne Corp. (TECH) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Bio-techne Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bio-techne Corp. share’s latest price of $57.4 as on November 8, 2025 at 2:29 am IST, you will get 0.1742 shares of Bio-techne Corp.. Learn more about
fractional shares .
What are the returns that Bio-techne Corp. has given to Indian investors in the last 5 years?
Bio-techne Corp. stock has given -24.08% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?